All News | FDA

Advertising & Promotion

Dec 30, 2022
FTC Expands Advertising Guide To Include All Health-Related Claims
Dec 23, 2022
Florida Supreme Court Considers Grand Jury Investigation of Manufacturers’ COVID-19 Vaccine Claims
Dec 19, 2022
FDA: Ads for Hypertension Drugs Should Cite Cardiovascular Outcome Claims
Dec 15, 2022
PMCPA Finds Novo Nordisk Breached ABPI Code in Weight Management Course Sponsorship
Dec 1, 2022
Teva and Allergan Agree to Nationwide Opioid Marketing Settlements
Nov 17, 2022
FDA Allows Makers of Six COVID-19 Drugs To Provide Safety, Efficacy Results in Promotional Material
Nov 9, 2022
Former Physician, Former Pharma Sales Rep Plead Guilty to Charges Related to Compounded Drug Scheme
Nov 6, 2022
Study: More Than a Third of Physicians, APCs Receive Industry Payments
Nov 3, 2022
Doctor, Avanir Sales Rep Plead Guilty to Fraud Conspiracy Charges Stemming from Kickback Scheme
Nov 1, 2022
IFPMA and EFPIA Provide Advice on Use of Social Media

Good Clinical Practice

Mar 24, 2023
FDA Extensively Revises Clinical Trial Electronic Records Guidance
Mar 17, 2023
Sponsor-Investigator Receives Warning Letter for Failing to Submit an IND
Mar 13, 2023
FDA BIMO Inspections Rebound in FY 2022
Mar 9, 2023
FDA Provides Roadmap for Externally Controlled Trials
Mar 1, 2023
Group Petitions FDA To Improve Enforcement of Trial Reporting Mandates
Feb 22, 2023
GAO Recommends More Oversight of IRBs
Feb 10, 2023
Former CRO Owner Debarred
Feb 3, 2023
Community Hospital IRB Receives Warning Letter Over Membership Concerns
Jan 29, 2023
FDA, NIH Asked To Explain Their Enforcement of Trial Reporting Requirements
Jan 23, 2023
FDA Debars Former Testing Site Owner

U.S. Food Labeling

May 24,2022
FDA Warns Companies About Selling Violative Supplements
May 12,2022
Draft Guidances Released on NAC as Supplement, How FDA Will Evaluate Non-listed Food Allergens
Apr 18,2022
Survey Finds ‘Organic’ Unclear to Consumers; Antibiotics Found in Cattle Labeled ‘RWA’
Apr 14,2022
FDA Upholds Position That NAC Is Not a Supplement, Promises Enforcement Guidance
Mar 31,2022
FDA Responds to Comments Received on ‘Healthy’ Symbol
Mar 17,2022
Association Continues To Press FDA on Changes to Artificial Sweetener Labeling
Mar 4,2022
District Court Rejects Claims That Food Products’ Labeling of Protein Content Was Misleading
Feb 17,2022
FTC Distributes Refunds to Supplement Purchasers
Feb 15,2022
Senate Narrowly Confirms Califf as FDA Commissioner
Feb 3,2022
FSIS Plans ‘Product of USA’ Labeling Survey, Seeks Input

FDA Regulation & Enforcement

Jan 5, 2025
Senators Want Payments to Advocacy Organizations Made Public
Jan 1, 2025
Manufacturer and Its President Plead Guilty to FD&C Act Violations in Marketing of Adulterated Fruit Juice
Dec 21, 2024
FDA’s Human Foods Program Sends Warning Letter Over Cookie Labeling
Dec 21, 2024
FDA Updates ‘Healthy’ Claim, Says FOP Proposal Out Soon
Dec 18, 2024
McKinsey To Pay $650 Million To Resolve Liability for Consulting Work Performed for Purdue Pharma
Dec 14, 2024
Senate Hearing Focuses on FOP and Other Labeling Issues
Dec 11, 2024
Biopharma, Clinical Research Executives Convicted on Charges Related to Scheme To Deceive Investors
Dec 11, 2024
CDRH Provides Early Alert of Potentially High-Risk Device Recall Under Pilot Program
Dec 10, 2024
Public Citizen Asks FTC To Examine Dr. Oz’s iHerb Social Media Posts
Dec 6, 2024
FDA, FSIS Want Information on Food Date Labeling

Medical Devices

Copyright © Thompson FDA, a division of CBIS. All rights reserved.